John C. Martin
American chemist and businessman · United States · On the map · Scientists · Lived 1951 to 2021 · aged 69
John Charles Martin was an American billionaire businessman, and the former executive chairman (2016-2018) and CEO (1996-2016) of the American biotechnology company Gilead Sciences. He joined Gilead Sciences in 1990 as vice president for research and development.
John C. Martin is read about 7.5 times a day, in 5 languages.
A typical day, 30 days to 24 September 2026
The middle day of the days counted, so one week of news cannot move it. The line under it is the last 60 days, one point a day.
Something wrong?Also in Deutsch
Awards
About this person
Gilead is known for developing drugs such as Atripla and commercializing Sovaldi (sofosbuvir) for the treatment of the liver virus hepatitis C. Martin is the recipient of a number of awards, including the Biotechnology Heritage Award (2017).